The 2023 ISPE Biotechnology Conference, held in Dublin, offers a comprehensive overview of the development and manufacturing of biotechnology products. This event focuses on the challenges faced by originator pharmaceuticals in increasing productivity, process intensification, flexibility, and agility for mass production. Attendees will have the opportunity to learn about modular facility design and collaborative project delivery, which are key factors in overcoming these challenges.

The conference specifically addresses the unique challenges of innovative, biosimilar, and follow-up biotechnology products, including cell and gene therapy, Advanced Therapeutic Medicinal Products (ATMPs), and mRNA-based products like vaccines. Presentations will cover important topics such as time to market, shortened submission approval times, product transfer, control strategy, quality oversight, manufacturing, and logistics. These discussions will be conducted within the current regulatory framework, ensuring attendees stay up to date with industry standards.

By attending the 2023 ISPE Biotechnology Conference, participants will gain insights into the methodologies that enable process development, supply chain resiliency, and sustainability, which is particularly crucial in light of the current energy crisis. The event serves as a platform for stakeholders across the pharmaceutical and biopharmaceutical value chain to share recent innovations, discuss practical challenges and solutions, and engage with industry leaders, regulators, and peers. Networking events and the conference program provide ample opportunities for meaningful connections and knowledge exchange.